ADVERTISEMENT
Executive Changes
Veteran pharma executive leads Vitamin Angels; CEO change to lead unifying Dr. Scholl's brand worldwide; and first CEO change for Prinova in 42 years.
HELP Committee members pepper Martin Makary with questions about his investments and potential conflicts of interest as commissioner. Makary’s transparency extends to saying FDA should “use common sense to ask some big questions we've never asked before,” including making more medical products available OTC.
Starboard Value CEO Jeffrey C. Smith and former Bayer consumer health chief Erica Mann among three added to board at Kenvue, which increasing the number of seats temporarily from 11 to 14 until trimming it to 13 at its 2025 annual shareholders meeting on a date yet to be set.
Ashley Graham promotes OLLY; Robles BioCeutics adds financial and science chiefs; Graham Rigby leads AHPA; Vit-Best Nutrition appoints Jeffrey Stallings president; BodyHealth collaborates with NBA player Bam Adebayo; and Bucked Up adds Alex Eubank as brand ambassador.
Along with its 2024 full-year and fourth-quarter results – both down slightly – the Los Angeles-based firm on 19 February announced its board appointed Stephan Gratziani, president since January 2024, as CEO effective 1 May.
Cosette Pharmaceuticals has made two key executive appointments as it looks to build up its business. Meanwhile, Canada’s CGPA has named a chair and vice-chair, and Chanelle and Neuraxpharm have announced their own executive changes.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
As Sandoz’s north American president Keren Haruvi gears up for a second term as chair of US generics and biosimilars association the AAM, other firms – including Sunshine Biopharma, Centrient and Rosemont – have also announced executive appointments.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.